Oxycodone 15 mg Immediate-Release (IR)

Product Overview

Oxycodone 15 mg Immediate-Release (IR) tablets provide rapid and effective relief of moderate to severe pain where opioid treatment is warranted in the analgesics category. This formulation is intended for patients who require prompt analgesic action to manage acute or chronic pain episodes that cannot be adequately managed by non-opioid therapies.

Oxycodone is a potent semi-synthetic opioid agonist that acts primarily on the mu-opioid receptors in the central nervous system, modifying the perception and response to pain. The immediate-release formulation allows the body to quickly absorb the active ingredient, providing timely pain control typically within 30 to 60 minutes after oral administration.

Key Features and Benefits

• Rapid Onset of Action: Designed for immediate-release and quick absorption to address sudden pain flare-ups.

• Effective Pain Management: Suitable for acute pain and breakthrough pain in patients on chronic opioid therapy.

• Flexible Dosing: Allows titration based on individual patient needs, facilitating precise pain control.

• Well-Characterized Safety Profile: With careful use, provides significant analgesia with manageable side effects.

• Available as a Tablet: Easy oral administration for patient convenience.

Indications

Oxycodone 15 mg IR tablets are indicated for the management of:

• Acute moderate to severe pain that requires opioid analgesics.

• Breakthrough pain episodes in patients receiving continuous opioid therapy.

It is intended for use when alternative pain management options are inadequate or inappropriate.

Dosage and Administration

• Healthcare providers must individualize the typical starting dose and titration schedule based on patient opioid tolerance, pain severity, and previous analgesic experience.

• Usually administered orally every 4 to 6 hours as needed for pain.

• Dose adjustments should be made cautiously to avoid overdose and adverse effects.

Patients should follow their healthcare provider’s instructions carefully to minimize risks associated with opioid therapy.

Pharmacology

Oxycodone hydrochloride, the active ingredient, is structurally distinct from morphine but shares opioid receptor affinity. It provides analgesic effects through agonism at central nervous system mu-opioid receptors. The immediate-release formulation dissolves quickly in the gastrointestinal tract, ensuring rapid blood plasma levels and effective pain relief.

Safety and Precautions

• Common Side Effects: Include nausea, dizziness, constipation, somnolence, and vomiting.

• Serious Risks: Respiratory depression, addiction, abuse, and misuse potential require careful patient monitoring.

• Contraindications: Hypersensitivity to oxycodone or any formulation components, respiratory depression, acute or severe bronchial asthma, or paralytic ileus.

• Drug Interactions: Caution advised with CNS depressants, benzodiazepines, and other opioids to avoid additive sedation or respiratory depression.

• Use in Special Populations: Adjust dosing and monitor closely in elderly, renal or hepatic impairment patients.

Packaging

• Tablets containing 15 mg of Oxycodone hydrochloride per unit.

• Oral administration for immediate pain relief.

• Package size as per regulatory and pharmaceutical supply standards.

About Vonage Pharma’s Commitment

Vonage Pharma dedicates itself to providing high-quality opioid analgesics with consistent efficacy and stringent safety measures. Our Oxycodone 15 mg Immediate-Release tablets meet international pharmaceutical manufacturing standards and offer healthcare providers a reliable solution for effective pain management.

Additional Information

For more detailed prescribing information and patient counseling guidelines, healthcare providers should refer to official product labeling and consult with Vonage Pharma’s medical affairs team.